SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is actively discussed after achieving a $1 trillion market cap and joining the Nasdaq-100, driven by its robust e-commerce and AI initiatives. However, the community remains divided, with many celebrating its defensive strength while others question its elevated valuation amidst a broader rotation into consumer staples.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network (PYTH) is gaining traction following its listing on Robinhood, alongside community excitement around its role as a leading oracle for Real World Assets (RWA) and its new PYTH Reserve initiative converting network revenue into token purchases. While many anticipate significant growth as an alternative to existing oracle solutions, some in the community express caution regarding future token unlocks and token concentration.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin is seeing a surge in community-driven trending activity as users actively push for increased visibility and anticipate a significant price surge. Enthusiasm is fueled by its perceived undervaluation as an AI-integrated cross-chain crypto exchange with a fully diluted supply, drawing comparisons to its history of rapid pumps.

Royal Gold, Inc. engages in the business of acquiring and managing precious metal streams, royalties, and similar interests. It operates under the Acquisition and Management of Stream Interests, and Acquisition and Management of Royalty Interests segments. The Acquisition and Management of Stream Interests segment focuses on metal streams, which are purchase agreements that provide, in exchange for an upfront deposit payment, the right to purchase all or a portion of one or more metals produced, at a price determined for the life of the transaction. The Acquisition and Management of Royalty Interests segment is involved in non-operating interests in mining projects that provide the right to revenue or metals produced from the project. The company was founded by Stanley Dempsey in 1981 and is headquartered in Denver, CO.

Royal Gold, Inc.

Royal Gold is gaining significant attention as gold and silver prices reach new highs, fueling strong financial results and a wave of analyst target upgrades. The community is highlighting the company's robust royalty streaming model and strategic acquisitions, positioning it as a 'money printer' benefiting from the broader metals rally.

Tidal Trust II - YieldMax COIN Option Income Strategy ETF

YieldMax COIN Option Income Strategy ETF

CONY is trending amid YieldMax's recent transition to weekly distributions, a move designed to address investor demand for more frequent payouts. The community is sharply divided, with discussions revolving around whether this shift and consistent dividend reinvestment can truly offset persistent NAV erosion and the impact of recent reverse splits, especially given the volatility of its underlying asset, Coinbase.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending amidst strong community conviction that a market bottom has been established and a Solana meme season is imminent, with many anticipating significant growth. Supporters are actively discussing its 'pure meme culture' and robust community, believing it's positioned for a major breakout.

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical, Risk, Legal Exhibitions and Print & print-related. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. The Risk segment provides customers with solutions and decision tools that combine public and industry specific content with advanced technology and analytics to assist them in evaluating and predicting risk and enhancing operational efficiency. The Legal segment is a global provider of legal, regulatory and business information and analytics that helps customers increase productivity, improve decision-making and outcomes and advance the rule of law around the world. The Exhibitions segment is an event business, enhancing the effect of face-to-face through data and digital tools. The Print & print-related segment consistent with financial information provided to the board. The company was founded by Albert Edward Reed in 1903 and is headquartered in London, the United Kingdom.

RELX Plc - ADR

RELX is trending following positive earnings and strong cash conversion, but the market is sharply divided as fears of AI disruption, particularly from new legal tools like Anthropics Claude, clash with the company's "content is king" moat and accelerating AI-driven growth. Many in the community believe the stock is deeply undervalued, presenting a "generational buying opportunity" for its high-quality data and content assets.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending after receiving early FDA approval for its menin inhibitor KOMZIFTI and achieving its first commercial sale, triggering a significant milestone payment from its partner Kyowa Kirin. The community is highlighting the drug's "best-in-class" safety profile and once-daily dosing, positioning it favorably against competitors as the company eyes expansion into lucrative first-line AML treatment and further pipeline development.

Lloyds Banking Group Plc is a financial services company, which engages in the provision of banking and financial services. It operates through the following segments: Retail, Commercial Banking, Insurance and Wealth, and Other. The Retail segment offers broad range of financial service products, including current accounts, savings, mortgages, motor finance and unsecured consumer lending to personal, and small business customers. The Commercial Banking segment provides a range of products and services such as lending, transactional banking, working capital management, risk management and debt capital markets services to SMEs, corporates, and financial institutions. The Insurance and Wealth segment focuses on the insurance, investment, and wealth management products and services. The Other segment refers to income and expenditure not attributed to the group’s financial reporting segments. These amounts include those arising from the group’s equities business, residual net interest income after transfer pricing, and certain gains from gilt sales. The company’s history roots are traced back to 18th century and Lloyds Banking Group was formed in January 2009 and is headquartered in London, the United Kingdom.

Lloyds Banking Group plc - ADR

Lloyds Banking Group is trending higher, fueled by recent strong financial results, a substantial dividend increase, and a new share repurchase program, alongside favorable resolution of the UK motor financing scandal. The community is noting its continued momentum to new 52-week highs, believing the stock remains undervalued compared to its peers and is now attracting wider institutional interest after surpassing key price levels.

Waystar Holding Corp. engages in the provision of healthcare organizations with mission-critical cloud software that simplifies healthcare payments. Its enterprise-grade platform streamlines the complex and disparate processes healthcare provider clients must manage to be reimbursed correctly, while improving the payments experience for providers, patients, and payers. The company was founded in 2000 and is headquartered in Lehi, UT.

Waystar Holding Corp

Waystar Holding Corp.

Waystar Holding Corp. is trending due to strong earnings and multiple analyst upgrades that highlight its AI-driven healthcare payment solutions. However, community discussions also reflect concerns over recent secondary offerings and insider selling following its IPO lock-up expiration.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Downgrades Arcutis Biotherapeutics (NASDAQ:ARQT) to Buy

Wall Street Zen cut Arcutis Biotherapeutics from a "strong-buy" rating to a "buy" rating in a research report on Saturday...

Arcutis Biotherapeutics Touts ZORYVE Expansion, New Indications and 2026 Cash-Flow Breakeven Goal

Executives from Arcutis Biotherapeutics (NASDAQ:ARQT) outlined their commercial priorities for the ZORYVE franchise, discussed potential label-expansion opportunities, and provided updates on...

Implied Volatility Surging for Arcutis Biotherapeutics Stock Options

Investors need to pay close attention to ARQT stock based on the movements in the options market lately. 

This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million Exit

Key PointsTejara Capital sold 520,503 shares of Arcutis Biotherapeutics in the fourth quarter...

Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Todd Watanabe Sells 19,833 Shares

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Todd Watanabe sold 19,833 shares of Arcutis Biotherapeutics stock in a transaction that occurred on Monday, February 2nd. The...

Tejara Capital Ltd Sells 352,878 Shares of Arcutis Biotherapeutics, Inc. $ARQT

Tejara Capital Ltd lessened its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) by 40.4% during the third quarter, according to the company in its most recent Form 13F filing...

Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Arcutis Biotherapeutics, Inc. $ARQT

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) in the third quarter, according to its most recent Form 13F filing...

Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Expected to Rise, Needham & Company LLC Analyst Says

Needham & Company LLC increased their price target on shares of Arcutis Biotherapeutics from $30.00 to $31.00 and gave the company a "buy" rating in a report on Monday...

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Given Average Rating of "Moderate Buy" by Analysts

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine brokerages that are presently covering the stock, MarketBeat...

Interesting ARQT Put And Call Options For September 18th

Investors in Arcutis Biotherapeutics Inc (Symbol: ARQT) saw new options become available this week, for the September 18th expiration. One of the key inputs that goes into the price an option buyer...

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Arcutis Biotherapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$25.86
Prev Close	$26.71
Open	$26.85
Dividend Yield	0.00%
50-Day Moving Average	$27.86
Beta	1.40
Avg. Volume	1.5M
PE Ratio	-72.95

52-Week High	$31.77
52-Week Low	$11.75
Market Capitalization	$3.17B
EPS (Annual)	-$1.16
Price to Book	19.68
Revenue Per Employee	$574,684.21

ARQT
Arcutis Biotherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARQT News

ARQTArcutis Biotherapeutics Inc